Albuzzer

Washington, US - September 30, ANI/Sputnik : The pharmaceutical company AstraZeneca will file a request for approval of its novel coronavirus vaccine in the US later this year, the company said in a statement.Earlier this year, concerns emerged over the side effects of the AstraZeneca vaccine due to very rare cases of blood-clotting after vaccination. After some nations temporarily suspended the use of the vaccine, the WHO said it considers the benefits of the drug to outweigh its risks."We continue to work with the FDA, US Food and Drug Administration] on submission," the company said on Wednesday. "Currently, the situation with respect to the pandemic and availability of alternative vaccine supply in the US doesn't really support an Emergency Use Approval. So, we believe that US approval will be via a BLA, Biologics License Applications] which we expect to be submitted later this year."

Related News